Pharmacogenetics of drug-induced arrhythmias. - Wikidata - awgldk - TriplyDB

Pharmacogenetics of drug-induced arrhythmias.

Pharmacogenetics of drug-induced arrhythmias.

http://www.wikidata.org/entity/Q38177332

about

Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.Novel exon 1 protein-coding regions N-terminally extend human KCNE3 and KCNE4.Ion channels under the sun.

P2860

Q34066888-90BAC833-EFA9-43C6-9267-AABDD8A23EA8 Q34525899-535BF0AB-1B12-445E-AC2D-208D75DCCDC8 Q37702927-2F064FB9-C965-4D0D-92D5-76C8929A0BF1

P2860

Pharmacogenetics of drug-induced arrhythmias.

http://www.wikidata.org/entity/Q38177332

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenetics of drug-induced arrhythmias.

@en

type

label

Pharmacogenetics of drug-induced arrhythmias.

@en

prefLabel

Pharmacogenetics of drug-induced arrhythmias.

@en

P1433

Q38177332-80D23DD9-2E99-4881-993B-BF80440E8E7D

P1476

Q38177332-8494CE6A-9FCC-472E-B301-BB85C46CAC05

P2093

Q38177332-10E23436-C89C-4FB0-9D89-2CCEA7AF7769

Q38177332-AF4D30E5-7F65-446D-A309-9996F32CAD23

P2860

Q38177332-009FC209-064B-4F53-A3C3-03B2700B6FAA

Q38177332-031D28C1-E21B-4F3D-8D90-5CB68B93FDF2

Q38177332-04D5E571-F824-48F4-BC7A-914B12D29712

Q38177332-0892705F-BCAC-4B70-9F6E-BF7E0354F95B

Q38177332-0AE19A51-E730-44C0-B6B8-554CBBB98330

Q38177332-0C9F052D-06F6-4195-8AF6-118F5F042B89

Q38177332-11188ADB-93F6-456D-BE06-69B28C4C5FAA

Q38177332-17CD1329-42A1-4FB5-902C-D4BB008D3935

Q38177332-1F5637B8-BDB4-4489-85CA-F43B11B59F39

Q38177332-1FA4118D-1BAA-462B-80C8-BEFC1A7A1214

P304

Q38177332-E65F05CF-BF6B-4B55-ADAB-506B3E2F100E

P31

Q38177332-C2BC9709-509F-4832-AE58-6E8D43F40B33

P356

Q38177332-E13A0788-9ADB-414F-B24B-1B6B189FCD26

P407

Q38177332-C4FD311A-F89B-4852-AFB6-1CF9BD9F01FC

P433

Q38177332-AE3C8622-EEAD-44ED-AB81-E2193F150EC7

P478

Q38177332-376A3331-BFAA-4BA1-8004-88D2001A99AF

P577

Q38177332-6E683DC3-71FF-4701-912B-E5D0B5F861B9

P698

Q38177332-50361DE2-99C2-4EA7-B82D-F63929FB0F91

P356

17512433.1.1.93

P1433

Expert Review of Clinical Pharmacology

P1476

Pharmacogenetics of drug-induced arrhythmias.

@en

P2093

Geoffrey W Abbott

http://www.w3.org/2001/XMLSchema#string

Torsten K Roepke

http://www.w3.org/2001/XMLSchema#string

P2860

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function

A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene

Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

HERG, a human inward rectifier in the voltage-gated potassium channel family

Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel

P304

93-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.1.1.93

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24410513

http://www.w3.org/2001/XMLSchema#string